Skip to Main Content


Select Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>

Launching soon: ASCI Emerging-Generation Awards

These awards recognize post-MD, pre-career physician-scientists who are meaningfully engaged in immersive research, giving them access to the Joint Meeting and longitudinal programming similar to the YPSA program. Entry into the ASCI network at this stage is intended to provide peer support and inspiration to stay the course into a physician-scientist faculty appointment.

Look for E-Gen Awards nominations to open in late October. Contact for more information.

Conquer Cancer Grants & Awards

These grants and awards support clinical and translational cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young investigators to senior researchers providing mentorship opportunities for the next generation of cancer researchers.

International Innovation Grant (IIG) - Application Deadline: December 2, 2022

Learn more about the Conquer Cancer Grant>>

Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1)
The ‘CASCADE’ Network will conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to overcome barriers and reduce failures in the cervical cancer screening, management, and precancer treatment cascade for women living with HIV.

Letter of Intent Due: November 28, 2022

AACR Clinical Oncology Research (CORE) Training Fellowships
This fellowship is designed for early-career clinical scientists who hold a medical degree (MD, DO, or MD/PhD) and are interested in acquiring the knowledge and skills related to drug development from the perspective of the pharmaceutical industry. The fellow will gain real-world experience in drug development, including clinical research, clinical trial design, and data analysis.

Application Deadline: November 30, 2022

Breast Surgery Fellowships

The term of the Breast Surgical Fellowship is one year with a grant award of $75,000, from August 1 through July 31. Institutions making application for the 2023 award must have an established breast fellowship program, be SSO accredited for a minimum of two years, and be located in New York, New Jersey or Connecticut.

Application Deadline: December 1, 2022

Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
This FOA invites applications for new institutional training programs (predoctoral, postdoctoral or both) in Artificial Intelligence (AI) for Precision Nutrition (AIPrN) focused on the integration of precision nutrition, AI, machine learning (ML), systems biology, systems science, Big Data, and computational analytics. The goal is to build a future workforce that will be able to use growing data resources to tackle complex biomedical challenges in nutrition science that are beyond human intuition.
Application Deadline: December 8, 2022

BCA Education and Outreach Grants

Breast Cancer Alliance offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, biopsies and mammograms for the underserved. The programs must be located in Connecticut and/or in Westchester County, New York.

Application Deadline: December 9, 2022

Alex’s Lemonade Stand Foundation 2023 Young Investigator Grant

The Young Investigator grant is a three-year award designed to support early career researchers, such as postdoctoral fellows, clinical fellows or instructors, pursuing promising childhood cancer research ideas. These grants aim to cultivate the best and brightest researchers of the future who demonstrate a commitment to a research career in pediatric cancer. A mentor is required, and a career development plan must be included. The Young Investigator grant offers up to $50,000 in direct costs per year for three years.

Application Deadline: December 12, 2022

AACR Immuno-oncology Research Fellowships

A joint effort to encourage and support postdoctoral or clinical research fellows to conduct immuno-oncology research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to immuno-oncology.

Application Deadline: December 14, 2022

Advancing Adolescent Tobacco Cessation Intervention Research (R34/R01)
The purpose of this FOA is to support studies that develop, test, implement, and evaluate behavioral tobacco cessation interventions for adolescents, with a focus on the critical developmental risk period of mid- to late adolescence (approximately 14-20 years old).
Application Opens: December 23, 2022

Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01)
Through this FOA, the NCI, NIDA, and NCCIH invite applications that propose prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment. NCI, NIDA, and NCCIH are seeking well-designed prospective cohort studies of cancer patients with solid or hematologic tumors currently receiving treatment. Studies are expected to compare cancer patients who use cannabis/cannabinoids with cancer patients that do not use cannabis and/or cannabinoids.

Application Deadline: February 17, 2023

Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01/R21)
Through this FOA, the NCI intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

Application Deadline: December 15, 2023

NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01)

This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) and enhance the diversity of the cancer research workforce, while promoting scientific advancements in cancer. Investigators from diverse backgrounds, including those from underrepresented groups are encouraged to work with their institutions to apply.

Application Deadline: February 6, 2024